1-3 of 3
Giampaolo Tortora
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Free
Davide Melisi, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, Paul J. Chiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 829–840.
https://doi.org/10.1158/1535-7163.MCT-07-0337
Published: 15 April 2008
View articletitled, LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Open the PDF for LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis in another window
Includes: Supplementary data
Journal Articles

In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches

Free
Bianca Maria Veneziani, Vittoria Criniti, Carla Cavaliere, Sara Corvigno, Agostina Nardone, Silvia Picarelli, Giampaolo Tortora, Fortunato Ciardiello, Gennaro Limite, Sabino De Placido
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (12): 3091–3100.
https://doi.org/10.1158/1535-7163.MCT-07-0356
Published: 18 December 2007
View articletitled, In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches
Open the PDF for In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches in another window
Journal Articles

Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model

Free
David Raben, Cataldo Bianco, Vincenzo Damiano, Roberto Bianco, Davide Melisi, Chiara Mignogna, Francesco Paolo D'Armiento, Luca Cionini, A. Raffaele Bianco, Giampaolo Tortora, Fortunato Ciardiello, Paul Bunn
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (8): 977–983.
https://doi.org/10.1158/1535-7163.977.3.8
Published: 06 August 2004
View articletitled, Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
Open the PDF for Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model in another window